Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Discover the top ten threat intelligence tools that every enterprise needs in 2025 to secure their operations efficiently. Learn about their features, integrations, and pricing models to make the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback